Albireo Team

Our unique GI experience gained from academia and many years experience in leading pharmaceutical organisations, combined with our track record in drug development, provides a strong platform for growth. Together with our well-established network among the leading scientists and key opinion leaders in the GI field, this puts us in an excellent position to be successful in the development of new and important GI therapeutics.


Dr Per-Göran Gillberg
VP Development
Dr Ingrid Påhlman
VP Pre-clinical
Dr Jan Mattsson
Chief Operating
Officer


Dr David Chiswell
Executive Chairman
Leif Rikner
Consultant on Drug
Development
Dr Hans Graffner
Chief Medical Officer

Björn Erlandsson
Director Finance
and Operations 
Terese Wallefors
Regulatory Affairs
Associate  

 
Cecilia Pramberg
Administrative
Co-ordinator